Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1960 2
1962 1
1963 2
1964 1
1965 2
1967 2
1968 1
1969 3
1970 3
1971 2
1972 4
1973 2
1974 7
1975 3
1976 5
1977 5
1978 11
1979 23
1980 28
1981 15
1982 33
1983 26
1984 37
1985 40
1986 43
1987 27
1988 11
1989 15
1990 10
1991 8
1992 8
1993 8
1994 5
1995 12
1996 7
1997 13
1998 7
1999 20
2000 24
2001 28
2002 29
2003 17
2004 20
2005 21
2006 14
2007 18
2008 21
2009 24
2010 24
2011 36
2012 34
2013 43
2014 28
2015 42
2016 43
2017 49
2018 44
2019 42
2020 47
2021 28
Text availability
Article attribute
Article type
Publication date

Search Results

1,061 results
Results by year
Filters applied: . Clear all
Page 1
Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial.
Saito H, Fukuhara T, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Gemma A, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M. Saito H, et al. Among authors: nagashima h. Lancet Oncol. 2019 May;20(5):625-635. doi: 10.1016/S1470-2045(19)30035-X. Epub 2019 Apr 8. Lancet Oncol. 2019. PMID: 30975627 Clinical Trial.
Rapid Enhancer Remodeling and Transcription Factor Repurposing Enable High Magnitude Gene Induction upon Acute Activation of NK Cells.
Sciumè G, Mikami Y, Jankovic D, Nagashima H, Villarino AV, Morrison T, Yao C, Signorella S, Sun HW, Brooks SR, Fang D, Sartorelli V, Nakayamada S, Hirahara K, Zitti B, Davis FP, Kanno Y, O'Shea JJ, Shih HY. Sciumè G, et al. Among authors: nagashima h. Immunity. 2020 Oct 13;53(4):745-758.e4. doi: 10.1016/j.immuni.2020.09.008. Epub 2020 Oct 2. Immunity. 2020. PMID: 33010223
Compensation of Disabled Organogeneses in Genetically Modified Pig Fetuses by Blastocyst Complementation.
Matsunari H, Watanabe M, Hasegawa K, Uchikura A, Nakano K, Umeyama K, Masaki H, Hamanaka S, Yamaguchi T, Nagaya M, Nishinakamura R, Nakauchi H, Nagashima H. Matsunari H, et al. Among authors: nagashima h. Stem Cell Reports. 2020 Jan 14;14(1):21-33. doi: 10.1016/j.stemcr.2019.11.008. Epub 2019 Dec 26. Stem Cell Reports. 2020. PMID: 31883918 Free PMC article.
Evaluation of plasma EGFR mutation as an early predictor of response of erlotinib plus bevacizumab treatment in the NEJ026 study.
Fukuhara T, Saito H, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada PM, Yoshimori K, Nakachi I, Gemma PA, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara PK, Nukiwa PT, Morita PS, Kobayashi PK, Maemondo PM. Fukuhara T, et al. Among authors: nagashima h. EBioMedicine. 2020 Jul;57:102861. doi: 10.1016/j.ebiom.2020.102861. Epub 2020 Jul 3. EBioMedicine. 2020. PMID: 32629391 Free PMC article. Clinical Trial.
1,061 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page